November 2008 - Page 66 of 76

MondayNov 03, 2008 4:35 am

OMNI Energy Services Corp. (NASDAQ: OMNI)

OMNI Energy Services Corp. (NASDAQ: OMNI), an integrated oilfield service company, specializes in providing a range of onshore seismic drilling, operational support, permitting, and survey services to geophysical companies operating in logistically difficult and environmentally sensitive terrain. The company also provides dock-side, onshore and offshore non-hazardous, oilfield waste management and environmental cleaning services, including tank and vessel cleaning and safe vessel entry, for oil and gas companies operating in the Gulf of Mexico. For further information, visit the Company's web site at www.omnienergy.com.

MondayNov 03, 2008 4:35 am

BELLUS Health, Inc. (NASDAQ: BLUS)

BELLUS Health, Inc. (NASDAQ: BLUS), a global health company, is committed to developing and commercializing products that provide innovative health solutions to address substantial, but unmet needs. The company’s wholly owned subsidiary, OVOS Natural Health Inc., aims to develop a strong franchise with several products marketed to help brain function as well as expand to other conditions. For further information, visit the Company's web site at www.bellushealth.com.

MondayNov 03, 2008 4:34 am

Bartronics India Limited (NSE: BARTRONICS)

Bartronics India Limited (NSE: BARTRONICS) is focused on providing businesses the ability to gain real-time visibility and information by utilizing the implementation, integration and support of Automatic Identification & Data Capture (AIDC) technologies, RFID, Smart Cards and Point of Sale (POS) solutions. Recognized as a dominant player in the domestic markets, the company has engaged in exclusive relationships with many of the leading vendors worldwide. For further information, visit the Company's web site at www.bartronicsindia.com.

MondayNov 03, 2008 4:33 am

Bayswater Uranium Corp. (TSX: ABAY CN)

Bayswater Uranium Corp. (TSX: BAY CN), a rapidly-growing international uranium exploration and development company, is the only uranium company to have major landholdings in each of Canada's most important producing and exploration regions -- the Athabasca Basin, the Central Mineral Belt, and the Thelon Basin. Additionally, the Company owns multiple advanced uranium properties in the United States that are being fast tracked to production. For further information, visit the Company's web site at www.bayswateruranium.com.

MondayNov 03, 2008 4:33 am

Avigen, Inc. (NASDAQ: AVGN)

Avigen, Inc. (NASDAQ: AVGN), a biopharmaceutical company, engages in the development and commercialization of small molecule therapeutics designed to treat serious neurological disorders, including neuropathic pain and opioid addiction and withdrawal. The company’s strategic aim is to complete the requirements of clinical development for each of the candidates in its product pipeline, while seeking opportunities to expand its pipeline through internal research, acquisitions, and in-licensing. For further information, visit the Company's web site at www.avigen.com.

MondayNov 03, 2008 4:32 am

AVI BioPharma, Inc. (NASDAQ: AVII)

AVI BioPharma, Inc. (NASDAQ: AVII) is committed to discovering and developing RNA-based drugs using its expanded portfolio of proprietary antisense compounds. Functional attributes of their unique approach may include correcting genetic defects, coding for novel soluble receptors, and the reduction in activity of immune modulators in disease states. Additionally, the company’s RNA-based drug programs include blocking mRNA translation. For further information, visit the Company's web site at www.avibio.com.

MondayNov 03, 2008 4:31 am

Avanir Pharmaceuticals (NASDAQ: AVNR)

Avanir Pharmaceuticals (NASDAQ: AVNR) is dedicated to acquiring, developing, and commercializing innovative therapeutic products designed to treat chronic diseases. Zenvia™, the company’s lead product candidate, is currently being developed to treat pseudobulbar affect (PBA). GlaxoSmithKline Consumer Healthcare currently markets Avanir’s first commercialized product, Abreva®, in North America. Abreva is the leading over-the-counter product for the treatment of cold sores. For further information, visit the Company's web site at www.avanir.com.

MondayNov 03, 2008 4:31 am

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS), a biopharmaceutical company, is focused on developing, manufacturing, and marketing a broad array of products based upon the shelf-stable Microcyn® Technology platform, which has been designed to help prevent and treat infections in wounds, burns and diseases. The Microcyn platform has shown capabilities of safely treating a wide range of pathogens, including antibiotic-resistant strains of bacteria such as MRSA, viruses, fungi and spores. For further information, visit the Company's web site at www.oculusis.com.

MondayNov 03, 2008 4:30 am

NutraCea (OTC BB: NTRZ)

NutraCea (OTC BB: NTRZ) is focused on processing and distribution stabilized rice bran and other proprietary, rice bran-based ingredients and formulations. Until recently, rice bran and germ were considered as a unnecessary by-product of the commercial rice-milling industry, but NutraCea recognized its unlimited potential as food and nutraceuticals ingredient. The company believes rice bran is positioned to become one of the world’s leading food ingredients for food manufacturers, nutraceuticals, humanitarian aid, as well as petfood and feed manufacturers. For further information, visit the Company's web site at www.nutracea.com.

MondayNov 03, 2008 4:30 am

Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX)

Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX), a biopharmaceutical company, is committed to discovering, developing and commercializing superior cancer therapeutics. The company's proprietary platform, AvalonRx®, is designed to discover and develop therapeutics for pathways that have been characterized as "undruggable” in the past. For further information, visit the Company's web site at www.avalonrx.com.

Site Search

Company Search

Month: November 2008